Posts in tag
abbvie
New drug in leukaemia fight
A new anti-cancer medication has been approved by the TGA for treatment of the most common type of leukaemia in Australia Venclexta (venetoclax) is a once-daily oral B-cell lymphoma-2 inhibitor …
A new anti-cancer medication has been approved by the TGA for treatment of the most common type of leukaemia in Australia Venclexta (venetoclax) is a once-daily oral B-cell lymphoma-2 inhibitor …
All content on AJP.com.au is restricted to registered users only.
To continue enjoying access to all the news, views, information and education you’ve come to trust, please login & stay in.
And if you don’t already have a login – register now!
